Glenmark Pharma, USA continues to expand its OTC portfolio with acquisition of approved ANDAs from… EP News Bureau Jun 28, 2022 Glenmark’s current portfolio consists of 175 products authorised for distribution in the US marketplace and 48 ANDAs pending…
